Market Access News | pharmaphorum

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J's Tremfya gets funding in Germany and UK

Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany.

News

Scotland's NHS to fund Ipsen cancer diarrhoea drug

Decision welcomed as step forward for patients

News

Genentech’s Rituxan approved for rare skin disease

The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.

News

Lung cancer drug Keytruda to become routinely available on N...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Fourth Humira biosimilar set for EU approval

European regulators have backed a new Humira biosimilar for approval, setting up a four-way race for the blockbuster’s market share later this year between Amgen, Boehringer Ingelheim, Sams

News